Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page
- Check5 days agoChange DetectedThe entry 2016 ( U.S. NIH Grant/Contract ) was added to the trial's list of identifiers, indicating a U.S. NIH funding attribution. This clarifies the funding source associated with the study.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA newer revision tag (v3.6.5) was added, replacing the previous revision (v3.6.4) for the study record, indicating an updated version of the page. This update appears to be an internal revision rather than a substantive change to the study details.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag on the page updated to v3.6.4, replacing v3.6.3. This indicates a minor update to the page rendering rather than changes to the study details.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a newer deployed version of the page. This change updates the visible revision tag on the site.SummaryDifference0.0%

- Check62 days agoChange DetectedA revision tag on the page is updated to v3.6.2, replacing the previous v3.6.0, indicating a small update to the page or its underlying system.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows a recruitment-status line 'No longer looking for participants' and adds new help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', with the Intervention/Treatment label introduced. Additionally, revision metadata updates to v3.6.0 and the label formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' to standardize presentation.SummaryDifference0.2%

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.